Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Stimulant Use (Diagnosis) clinical trials
2 of 3 indexed Stimulant Use (Diagnosis) trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Stimulant Use (Diagnosis): 3 US clinical trials tracked, 2 recruiting.
Stimulant Use (Diagnosis) is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Northwestern University, running 1 of these trials.
Enrollment posture brief
Registry condition stimulant-use-diagnosis
OPEN 2 | RECR 67% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Stimulant Use (Diagnosis) lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Stimulant Use (Diagnosis) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Stimulant Use (Diagnosis) is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations
Northwestern University
NCT05702021
HIV, Equity, and Addiction Training (HEAT) Program
University of Alabama at Birmingham
NCT06370481
Contingency Management in HIV Care for Both Stimulant Use & ART Adherence
University of California, San Francisco
NCT06564792
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Stimulant Use (Diagnosis) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Stimulant Use (Diagnosis) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Stimulant Use (Diagnosis) page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Stimulant Use (Diagnosis) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Northwestern University sponsors the most Stimulant Use (Diagnosis) trials on record, review their full trial history before evaluating a specific study. See Northwestern University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stimulant Use (Diagnosis) condition card totals 3 registered trials; most-linked intervention Contingency management; top US site state Rhode Island. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.